Huhtamaki India shares jump 15% after strong Q3 results and margin expansion
Huhtamaki India shares surged 15% in intraday trade after the company posted a sharp turnaround in Q3 FY25, driven by lower input costs and operational efficiencies. Net profit stood at ₹54 crore versus a ₹3.2 crore loss last year. Revenue rose 9% YoY to ₹750 crore, supported by strong packaging demand from FMCG and pharmaceutical clients. EBITDA margins improved by 210 basis points to 11.5%. Analysts expect steady demand momentum from staples and healthcare, citing improved cost discipline and resilient export volumes.
positive
3 days ago
Huhtamaki India shares jump 15% after strong Q3 results and margin expansion
Huhtamaki India shares surged 15% in intraday trade after the company posted a sharp turnaround in Q3 FY25, driven by lower input costs and operational efficiencies. Net profit stood at ₹54 crore versus a ₹3.2 crore loss last year. Revenue rose 9% YoY to ₹750 crore, supported by strong packaging demand from FMCG and pharmaceutical clients. EBITDA margins improved by 210 basis points to 11.5%. Analysts expect steady demand momentum from staples and healthcare, citing improved cost discipline and resilient export volumes.
positive
Huhtamaki India shares jump 15% after strong Q3 results and margin expansion
3 days ago
1 min read
82 words
Huhtamaki India stock jumps 15% after Q3 turnaround, aided by cost control and margin improvement.
Huhtamaki India shares surged 15% in intraday trade after the company posted a sharp turnaround in Q3 FY25, driven by lower input costs and operational efficiencies. Net profit stood at ₹54 crore versus a ₹3.2 crore loss last year. Revenue rose 9% YoY to ₹750 crore, supported by strong packaging demand from FMCG and pharmaceutical clients. EBITDA margins improved by 210 basis points to 11.5%. Analysts expect steady demand momentum from staples and healthcare, citing improved cost discipline and resilient export volumes.
Huhtamaki India shares surged 15% in intraday trade after the company posted a sharp turnaround in Q3 FY25, driven by lower input costs and operational efficiencies. Net profit stood at ₹54 crore versus a ₹3.2 crore loss last year. Revenue rose 9% YoY to ₹750 crore, supported by strong packaging demand from FMCG and pharmaceutical clients. EBITDA margins improved by 210 basis points to 11.5%. Analysts expect steady demand momentum from staples and healthcare, citing improved cost discipline and resilient export volumes.